Canaccord Genuity Initiates Tonix Coverage With Buy Rating, $18 Target
Canaccord Genuity initiated coverage of Tonix Pharmaceuticals with a Buy rating and an $18 price target.
Canaccord Genuity initiated coverage of Tonix Pharmaceuticals with a Buy rating and an $18 price target.